down arrow

Daito Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3486150000
  • TKS: 4577
JPY
1,350.00
17 (1.28%)

Sep 24

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
May'26
May'25
May'24
May'23
May'22
May'21
May'20
Net Sales
50,650.00
50,643.00
46,895.00
45,101.00
43,464.00
48,709.17
44,997.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
50,650.00
50,643.00
46,895.00
45,101.00
43,464.00
48,709.17
44,997.11
Raw Material Cost
40,753.00
42,169.00
37,221.00
34,946.00
32,157.00
38,049.26
35,626.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
130.00
123.00
41.00
12.00
9.00
7.85
11.88
Selling and Distribution Expenses
4,037.00
3,333.00
3,431.00
3,078.00
2,990.00
2,710.93
2,607.26
Other Expenses
209.30
239.70
230.80
185.30
174.00
202.48
138.87
Total Expenditure (Excl Depreciation)
47,013.00
48,022.00
43,001.00
39,889.00
36,896.00
42,792.85
39,634.40
Operating Profit (PBDIT) excl Other Income
3637
2621
3894
5212
6568
5916.3
5362.7
Other Income
521.00
493.00
322.00
-115.00
327.00
156.28
404.34
Operating Profit (PBDIT)
8,545.00
7,446.00
7,875.00
8,967.00
10,208.00
9,226.93
8,717.54
Interest
130.00
123.00
41.00
12.00
9.00
7.85
11.88
Exceptional Items
36.00
-33.00
45.00
-8.00
-166.00
-190.85
-160.03
Gross Profit (PBDT)
9,897.00
8,474.00
9,674.00
10,155.00
11,307.00
10,659.91
9,370.53
Depreciation
4,387.00
4,332.00
3,659.00
3,870.00
3,313.00
3,154.33
2,950.48
Profit Before Tax
4,065.00
2,958.00
4,218.00
5,076.00
6,720.00
5,873.91
5,595.15
Tax
928.00
1,192.00
1,040.00
1,549.00
2,092.00
1,716.87
1,670.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,161.00
1,908.00
3,294.00
3,599.00
4,667.00
4,246.46
3,944.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,161.00
1,908.00
3,294.00
3,599.00
4,667.00
4,246.46
3,944.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-25.00
-143.00
-116.00
-72.00
-40.00
-89.42
-19.97
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,136.00
1,765.00
3,178.00
3,527.00
4,627.00
4,157.03
3,924.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
52,892.00
52,003.00
52,069.00
50,672.00
47,307.00
41,618.96
36,509.21
Earnings per share (EPS)
107.47
62.72
105.0
113.72
152.45
141.38
139.75
Diluted Earnings per share
107.47
62.72
105.0
113.72
152.45
141.38
139.75
Operating Profit Margin (Excl OI)
7.18%
5.18%
8.3%
11.56%
15.11%
12.15%
11.92%
Gross Profit Margin
16.69%
14.39%
16.8%
19.84%
23.08%
18.53%
18.99%
PAT Margin
6.24%
3.77%
7.02%
7.98%
10.74%
8.72%
8.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2026 is 0.01% vs 7.99% in May 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended May 2026 is 77.68% vs -44.46% in May 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2026 is 15.40% vs -7.94% in May 2025

stock-summary

Interest

YoY Growth in year ended May 2026 is 5.69% vs 200.00% in May 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended May 2026 has improved from May 2025

Compare Annual Results Of Daito Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
50,650.00
0.00
50,650.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
50,650.00
0.00
50,650.00
Raw Material Cost
40,753.00
8.05
40,744.95
506,148.45%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
457.28
-457.28
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
130.00
81.06
48.94
60.38%
Selling and Distribution Expenses
4,037.00
1,108.67
2,928.33
264.13%
Other Expenses
209.30
213.97
-4.67
-2.18%
Total Expenditure (Excl Depreciation)
47,013.00
3,794.81
43,218.19
1,138.88%
Operating Profit (PBDIT) excl Other Income
3,637.00
-3,794.81
7,431.81
195.84%
Other Income
521.00
-415.87
936.87
225.28%
Operating Profit (PBDIT)
8,545.00
-4,202.63
12,747.63
303.33%
Interest
130.00
81.06
48.94
60.38%
Exceptional Items
36.00
0.00
36.00
Gross Profit (PBDT)
9,897.00
-8.05
9,905.05
123,044.10%
Depreciation
4,387.00
8.05
4,378.95
54,396.89%
Profit Before Tax
4,065.00
-4,291.74
8,356.74
194.72%
Tax
928.00
-449.13
1,377.13
306.62%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,161.00
-3,842.61
7,003.61
182.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,161.00
-3,842.61
7,003.61
182.26%
Share in Profit of Associates
0
0
0.00
Minority Interest
-25.00
0.00
-25.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,136.00
-3,842.61
6,978.61
181.61%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
52,892.00
13,604.67
39,287.33
288.78%
Earnings per share (EPS)
107.47
-52.55
160.02
304.51%
Diluted Earnings per share
107.47
-52.55
160.02
304.51%
Operating Profit Margin (Excl OI)
7.18%
0.00%
0.00
7.18%
Gross Profit Margin
16.69%
0.00%
0.00
16.69%
PAT Margin
6.24%
0.00%
0.00
6.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,065.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 0.01% vs 7.99% in May 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 313.60 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 77.68% vs -44.46% in May 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 802.40 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 15.40% vs -7.94% in May 2025

Annual - Interest
Interest 13.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 5.69% vs 200.00% in May 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.18%
in May 2026

Figures in %
stock-summary

YoY Growth in year ended May 2026 has improved from May 2025

Footer loading